Inhibiting TGF-β to increase response rates to chemoradiotherapy in rectal cancer Editorial

  

Authors:	Romesser, P. B.; Smith, J. J.
Title:	Inhibiting TGF-β to increase response rates to chemoradiotherapy in rectal cancer
Keywords:	treatment outcome; treatment response; retrospective studies; unspecified side effect; note; neoadjuvant therapy; transforming growth factor beta; retrospective study; organ preservation; immunophenotyping; rectal neoplasms; rectum cancer; rectum tumor; radiosensitizing agent; chemoradiotherapy; immune checkpoint inhibitor; consolidation chemotherapy; humans; human; tgf beta signaling; galunisertib
Journal Title:	Lancet Oncology
Volume:	23
Issue:	9
ISSN:	1470-2045
Publisher:	Elsevier Science, Inc.
Date Published:	2022-09-01
Start Page:	1116
End Page:	1118
Language:	English
DOI:	10.1016/s1470-2045(22)00504-6
PUBMED:	36055299
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137106398&doi=10.1016%2fS1470-2045%2822%2900504-6&partnerID=40&md5=69761c4bfeb7a840728d51e6b1cc3a21
Notes:	Note -- Export Date: 3 October 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/198184